| Code | 3573E | ||||||||||
| MA number | 42/0114/23-S | ||||||||||
| Product Form: | cps mdd 2x100 mg (blis.PVC/Aclar/Al) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Olpha AS, Latvia | ||||||||||
| Therapeutic Class: | 42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK) | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 24 | ||||||||||
| Container: | blister PVC/Aclar/Al | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 02.05.2023 |
| Validity: | 02.05.2028 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| Pediatric contraindication: | Yes |
| PIL: |
PIL_Nostiriazyn 100 mg tvrdé kapsuly s riadeným uvoľňovaním_02.2025.pdf
|
| SPC: |
SPC_Nostiriazyn 100 mg tvrdé kapsuly s riadeným uvoľňovaním_02.2025.pdf
|
| Safety feature | Yes |
| Data update: | 25.03.2024 |
